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Background: Leishmaniasis is a neglected vector-borne tropical disease caused by Leishmania protozoa that are
transmitted to mammalian hosts by infected sand flies. Infection is associated with distinct clinical manifestations
that include cutaneous, mucocutaneous and visceral lesions. Visceral leishmaniasis (VL) is the most severe form of
the disease and is considered second in terms of mortality and fourth in terms of morbidity among tropical
diseases. IFN-γ-producing T cells are involved in protection against the disease.
Methods: CD43+/+ and CD43-/- mice on a C57BL/6 background were intravenously injected with 5 × 10 7
amastigotes of Leishmania (L.) infantum chagasi, and 30 days after infection the clinical signs of disease were
examined; the splenocytes were isolated and assayed for cytokine production; and the livers were removed for
phenotypic analysis of T cell subsets by flow cytometry.
Results: We report that mice lacking CD43 display increased susceptibility to infection by Leishmania (L.) infantum
chagasi, with higher parasite burdens than wild-type mice. The increased susceptibility of CD43−/− mice were
associated with a weakened delayed hypersensitivity response and reduced levels of IgG2a antibodies to leishmania
antigens. We further showed that expression of CD43 defines a major intrahepatic CD4+ and CD8+ T cell subsets
with pro-inflammatory phenotypes and leads to increased levels of IFN-γ secretion by activated splenocytes.
Conclusions: Our findings point to a role of CD43 in the development of host resistance to visceral leishmaniasis.
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Host protective responsesBackground
Infection with leishmania spps can induce diseases varying
from local cutaneous lesions to systemic visceral manifesta-
tions. Parasites of the intracellular protozoan, Leishmania,
are transmitted to mammalian hosts by sand fly vectors.
The parasites have a dimorphic life cycle consisting of
extracellular promastigotes in the vector, and intracellular
amastigotes inside mammalian macrophages [1]. The dif-
ferent pathologies are associated with different degrees of* Correspondence: morrot@micro.ufrj.br
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unless otherwise stated.parasite spread. Parasite species such as L. major are con-
fined to cutaneous lesions while others such as L. donovani
and Leishmania (L.) infantum chagasi have the capability to
disseminate into visceral organs such as spleen and liver,
and bone marrow causing visceral leishmaniasis, the most
severe form of the disease [2]
Adaptive immunity against leishmaniasis is associated
with development of T cell-mediated interferon-gamma
(IFN-γ) responses. IFN-γ secreted by CD4+ and CD8+ T
cells mediates the respiratory burst in activated macro-
phages which is responsible for the production of nitric
oxide needed for parasite killing inside reservoir cells
[3,4]. Other cytokines can modulate the anti-parasite ac-
tivity promoted by IFN-γ. It has been demonstrated thatis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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by inducing IFN-γ, which activates macrophages to kill
intracellular parasites in granulomas formed in parasitized
tissue foci [5,6]. While it has been shown that TNF-α is
able to enhance the macrophage leishmanicidal activity in-
duced by IFN-γ, increased levels of IL-10 oppose macro-
phage activation by blocking Th1 cellular responses [4,7].
Other host determinants are associated to subclinical
and symptomatic infections by leishmania species. In the
visceral form of the disease, Nramp1 (natural resistance-
associated macrophage protein one) induces inflammatory
responses that limit proliferation of the intracellular
pathogen in macrophage reservoirs [8]. Other cytokines
such as IL-4 [9,10] and TGF-β [11] are associated with in-
creased host susceptibility to the infection. In humans,
polymorphism for CXCR2 as well as for Notch 3 Delta-
like 1 ligand, which drives CD4 T helper 1 cell responses,
contributes to susceptibility to visceral leishmaniasis and
affects the outcome of the disease [12,13].
Studies of the key gene products controlling infection
are important for developing interventions aimed at stimu-
lating Th1-type responses and enhancing resistance to
leishmania infection. Optimal activation of anti-leishmanial
Th1 responses requires costimulatory signals triggered by
the interaction of surface molecules on T cells and antigen-
presenting cells. The activation of signal-transducing re-
ceptor pathways promoted by the interaction between
CD40 ligand-CD40 and CD28-B7 in immunological synap-
ses can stimulate Th1 type responses and enhance resist-
ance to various forms of experimental leishmaniasis [14].
In the present study we investigated the role of a third
class of costimulatory receptors represented by CD43
(leukosialin), which is involved in the induction of Th1
responses in other models such as autoimmune enceph-
alomyelitis [15] and diabetes [16]. CD43 is a large sialo-
glycoprotein highly expressed by T cells; it is abundant
on the T cell surface, and interacts with the T cell recep-
tor to initiate signaling events during T cell priming [17].
CD43 signals potentiate the expression of IFN-γ by T
cells during TcR activation of naïve cells, and the CD43
signaling pathway induces the expression of IFN-γ by ef-
fector CD4+ T cells and to a lesser extent CD8+ T cells [18].
Synergism between the CD43 and TcR signaling path-
ways promotes increased transcription of T-bet genes in
CD4+ T cells and inhibits the transcription of GATA-3
genes in both CD4+ and CD8+ T cells, a commitment
profile characteristic of IFN‐γ‐producing type 1 T cells
[18]. Beside its dynamic role in progression of the T cell
differentiation program, CD43 plays a positive role in T
cell homing from lymphoid organs to peripheral tissues
[16,19,20]. In the experimental meningitis model in-
duced by lymphocytic choriomeningitis virus (LCMV),
infection of CD43−/− mice led to increased morbidity
associated with decreased trafficking of virus-specificCD8+ Tcells to tissues such as the brain [21]. Other studies
using anti-CD43 antibody to block T cell migration to pan-
creatic islets in non-obese diabetic mice have highlighted
the role of CD43 in the costimulation and trafficking of T
cells, which can prevent autoimmune diseases such as
insulin-dependent diabetes mellitus [16].
Given the positive regulatory role of CD43 in the in-
duction of IFN‐γ‐dependent T cell responses and the
homing properties of T cells to peripheral non-lymphoid
organs where most interactions with pathogens take
place, we sought to characterize the importance of CD43
in an experimental model of visceral leishmaniasis. In
this study we evaluated the potential role of CD43 in vis-
ceral leishmaniasis using C57BL/6 wild type mice and




All mouse studies followed the guidelines set by the
National Institutes of Health, USA. The study was ap-
proved by the Research Ethics Committee of Federal
University of Rio de Janeiro, (protocol IMPPG040-07/16).
Protocols for animal were approved by the Institutional
Ethical Committees in accordance with international
guidelines. All animal experimentation was performed in
accordance with the terms of the Brazilian guidelines for
animal welfare regulations.
Animals and infection
C57BL/6 wild type control mice and C57BL/6 CD43−/−
knock-out (CD43−/−) originated from breeding colonies
kindly donated by Professor Anne Sperling (University
of Chicago, USA) were maintained in our animal facil-
ities (UFRJ). Experimental infection was performed by
inoculating 4–8 week-old female C57BL/6 CD43+/+and
CD43−/−mice intravenously with 5 × 107 Leishmania (L.)
infantum chagasi amastigotes (IOC-L 3324) obtained
from infected hamster spleens.
Intrahepatic parasite load and delayed-type hypersensitivity
(DTH) assay
Thirty days after infection, mice were euthanized and the
liver parasite load was evaluated in Giemsa-stained smears
and expressed in LDU values (Leishman Donovan units of
Stauber = number of amastigotes per 1000 liver cell nuclei/
mg of liver weight). The DTH against L. (L.) donovani
lysate was measured in the footpads at 28 days post-
infection by intradermally injection in the right front foot-
pad with 107 freeze-thawed stationary phase Leishmania
(L.) infantum chagasi (L579 Fiocruz) promastigotes in 100
μl sterile saline solution. Footpad thicknesses were mea-
sured as described at 0, 24 and 48 h after injection, and
the values of the saline control in the contra-lateral
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Leishmania antigen.
Flow cytometry
For T cell phenotyping experiments, spleens were re-
moved from infected and control animals. The organs
were minced, washed and resuspended in PBS-FCS 5% for
subsequent evaluation of cellularity, which was followed
by triple or quadruple immunofluorescence staining. Cells
were then fixed and analyzed by flow cytometry in a
FACSCalibur flow cytometer. Analyses were done after re-
cording 25,000–50,000 events for each sample, using a
CELLQuest software (Becton Dickinson). Lymphocytes
were gated based on forward and side scatter parameters,
so as to avoid larger leukocytes such as macrophages and
granulocytes. For determination of the cytokine mRNA
transcripts expressed on T cells, CD4+ and CD8+ T cell
subsets was obtained based on the expression of the CD43
marker by FACS cell sorting using anti CD3-APC, anti
CD4-PERCP, anti CD8-PE and anti-CD43-FITC. After
FACS cell sorting, the total RNA from isolated T cells was
extracted using TRIzol (Invitrogen, Life Technologies) and
reverse-transcribed to cDNA with SuperScript TM III
Reverse Transcriptase (Invitrogen, Life Technologies).
Quantification of mouse cytokine mRNA transcripts
Real-time PCR was performed with the ABI Prism 7900HT
Fast Real-Time PCR System instrument (Applied Biosys-
tems) using the qPCR SYBR Green Core Kit (Eurogentec)
according to the manufacturer’s instructions. The amplifi-
cation program included an initial denaturation step at
95°C for 10 min, followed by denaturation at 95°C for 15 s,
and annealing and extension at 60°C for 1 min, for 45 cy-
cles. SYBR Primers used to amplify specific gene products
from murine cDNA were IFN-γ sense, 5′-cggcacagtcatt
gaaagcc-3′; IFN-γ antisense, 5′-tgtcaccatccttttgccagt-3′;
TNF-α sense, 5′-ttctatggcccagaccctca-3′; TNF-α antisense,
5′-gtggtttgctacgacgtggg-3′; TGF-β sense, 5′-accgcaacaacgc
catctat-3′; TGF-β antisense, 5′-tgcttcccgaatgtctgacg-3′; IL-
17 sense, 5′- tctttaactcccttggcgca-3′; IL-17 antisense, 5′-
ttcattgcggtggagagtcc-3′; IL-10 sense, 5′-tgaattccctgggtga
gaagc-3′; IL-10 antisense, 5′-acaggggagaaatcgatgacag-3′;
GAPDH sense, 5′-tgcaccaccaactgcttagc-3′; GAPDH anti-
sense, 5′-ggcatggactgtggtcatgag-3′. Green fluorescence was
measured after each extension step, and the specificity of
amplification was evaluated by melting curve analysis. The
relative gene expression levels were calculated using the
comparative Ct method (according to Applied Biosystems),
where Ct represents the threshold cycle. Every sample was
run in three parallel reactions.
Anti-Leishmania (L.) infantum chagasi ELISA
Isotype specific serum antibody responses were monitored
by an enzyme-linked immunosorbent assay (ELISA) usingthe freeze and thawed lysate of stationary phase promasti-
gotes of Leishmania (L.) infantum chagasi (L579 Fiocruz)
as antigen. Whole parasite antigens were diluted to 2 μg/ml
in PBS buffer (pH 7.0), and separately added at 100 μl/well
to 96 well plate. After overnight incubation at 4°C, the
plates were washed three times using PBS containing 0.05%
(vol/vol) Tween 20 (Sigma, Gillingham, UK). Serial two-
fold 1:100 to 1:800 dilutions of serum samples obtained
from infected mice at 30 days post-infection (DPI) and
normal mice as control diluted in PBS containing
0.05% Tween were added to the plates and incubated at
37°C for 1 hr. Following three washes with PBS con-
taining 0.05% Tween, 1:5,000 dilution of peroxidase-
labelled each goat anti-mouse Ig isotypes (IgG1,IgG2a
and IgG2b) (Jackson ImmunoResearch, West Grove,
USA) prepared in PBS containing 0.05% Tween was added
at 100 μl/well and the plates incubated at 37°C for 1 hr.
Following six washes with PBS containing 0.05% Tween,
the reaction was developed with 50 mM phosphate/citrate
buffer (pH 5.0) containing 2 mM o-phenylenediamine
HCl and 0.007% (vol/vol) H2O2 (Sigma, UK), and inter-
rupted with the addition of 2 M H2SO4 (50 μl/well). The
ELISA plates were read at 490 nm (Spectra Max 190,
Molecular Devices, Sunnyvale, USA).
T Cell activation and Cytokine assays
For restimulation assay, splenocytes (1 × 106/0,5 mL) ob-
tained from control or infected mice at day 30 DPI were
cultured in 48 well at 37°C and 5% CO2 in complete RPMI
medium, in the presence or not of 106 freeze-thawed
stationary phase Leishmania (L.) infantum chagasi (L579
Fiocruz) promastigotes. After 3 days of in vitro stimu-
lation, supernatants were collected and cytokine levels
(IFN-γ, TNF-α, IL-10 and TGF-β) were assayed by ELISA
utilizing purified and biotinylated Abs (R&D Systems),
biotin-conjugated streptavidin-alkaline phosphatase (BD
Pharminge) and developed with ELISA Develpment Kit
from R&D System according to the manufacturer’s in-
structions. Plates were read at 405 nm and values are pre-
sented as pg cytokine/mL (mean ± SE).
Statistical analysis
Statistical analyses were performed with GraphPad Prism 4
software, using one-way ANOVA and Turkey test. Results
were expressed as mean ± standard error (S.E.), Differences
between control and treated group were considered statis-
tically significant when P ≤ 0.05.
Results
Expression of leukosialin (CD43) is critical for resistance
to visceral leishmaniasis
Visceral leishmaniasis is characterized by multiple organ
infections that promote systemic immune responses. At
the outset of infection the liver contains infected tissues
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the target of anti-leishmania T cell protective immune
responses [22]. We examined the relevance of CD43-
mediated IFN-γ responses in antileishmanial immunity,
and their role in inhibiting intrahepatic development of
the parasite. To this end, we used a murine model of VL
in which infection of C57BL/6 mice with Leishmania
(L.) infantum chagasi amastigotes gives rise to a higher
parasite load in the liver than in other organs such as
the spleen and bone marrow during the first weeks, after
which it is controlled by the host immune response.
We observed a lower DTH response to the promasti-
gote leishmania antigen in CD43−/− mice on a C57BL/6
background than in wild type C57BL/6 mice after infec-
tion with Leishmania (L.) infantum chagasi (Figure 1A).
These data indicate that cellular immunity against vis-
ceral infection of leishmania parasite is impaired in
knockout mice, raising the possibility that CD43 is re-
quired for optimal development of host resistance to VL.
We next examined the signs of acute infection in the
liver. Following intravenous infection with amastigote
forms of Leishmania (L.) infantum chagasi we observed
that the increased susceptibility of CD43-deficient miceFigure 1 CD43 deficient mice are susceptible to visceral leishmaniasis
intravenously injected with 5 × 10 7 amastigotes of Leishmania (L.) infantum ch
examined. (A) Infection in CD43-deficient mice results in an impaired DTH res
of the thickness of the skin reaction in mm 24 h and 48 h after intradermal in
Controls with saline were done by contra-lateral injection and their values we
(B) Liver/body relative weights are increased in infected CD43-deficient mice.
relative weights (grams of organ weight × 100 / grams of body weight) were
in the liver of CD43-deficient mice. The vertical axis in the histogram represen
(LDU = number of amastigotes / 1000 cell nuclei × organ weight in mg) obtai
independent experiments performed with 5–6 mice per treatment. Differencewas correlated with greater increases in the liver/body
weight ratio (Figure 1B) and intrahepatic parasite burden
at 30 days post-infection in CD43−/− mice than in the
wild-type control mice (Figure 1C).The increased susceptibility of CD43-deficient mice infected
with Leishmania (L.) infantum chagasi is associated with a
switch in the humoral response and diminished levels of
IFN-γ
Resistance to visceral infection by Leishmania species is
associated with the IgG isotype profile [23]. Hence, we
measured specific IgG antibody levels in mouse serum
to determine whether the impaired resistance of CD43-
deficient mice is associated with a switch in the IgG sub-
type profile. Serum samples were collected at day 30
post-infection and IgG titers were determined by ELISA.
We found that levels of IgG2a parasite-specific anti-
bodies in infected CD43−/− mice were significantly lower
than in infected wild-type mice (Figure 2). On the other
hand, the IgG1 and IgG2b antibodies themselves, from
both groups, did not differ significantly in their reactivity
to lysates (Figure 2).. CD43+/+ and CD43−/− mice on a C57BL/6 background were
agasi, and 30 days after infection the clinical signs of disease were
ponse. The vertical axis in the histogram represents the individual values
jection of 107 freeze–thawed stationary phase promastigotes at 30 DPI.
re subtracted from the reaction promoted by Leishmania antigen.
The body weight was measured in grams at day 30 and the liver/body
determined in CD43+/+ and CD43−/− mice. (C) Increased parasite burden
ts the average liver parasite load in Leishman-Donovan units of Stauber
ned at 30 DPI. Data are means ± SE and represent the results of three
s between groups are significant *(p < 0.05).
Figure 2 IgG profile of serum antibodies to Leishmania (L.)
infantum chagasi of CD43-deficient mice. Sera of CD43+/+ and
CD43−/− mice infected with 5 × 107 amastigote forms of Leishmania
(L.) infantum chagasi were collected at 30 DPI and the absorbance
values of IgG antibody isotypes (IgG1, IgG2a and IgG2b) were
determined by ELISA using Leishmania (L.) infantum chagasi
promastigote lysates. Bars show levels of IgG1, IgG2a and IgG2b
antibodies as the individual absorbancy values of 1/100 diluted sera.
Asterisks indicate significant differences between groups ***(p < 0.001).
Data represent the individual results for each group of mice of two
independent experiments.
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in leishmaniasis is the development of a strong IFN-γ re-
sponse, which induces IgG2a production [23]. We there-
fore compared the cytokine responses to infection with
Leishmania (L.) infantum chagasi parasites by analyzing
the cytokines in supernatants of splenocytes isolated from
infected wild-type and knockout mice stimulated with
whole parasite antigens for 3 days. Splenocytes obtained
from infected wild-type mice at 30 DPI when stimulated
with parasite antigen mounted a typical protective pro-
inflammatory response characterized by high levels of
IFN-γ and low levels of TGF-β (Figure 3A, B). In contrast,
the splenocytes from infected CD43−/− mice produced re-
duced levels of IFN-γ and high levels of TGF-β upon
stimulation with parasite antigens (Figure 3A, B). This
clearly demonstrates that CD43-deficient mice have im-
paired immune response generation after infection with
Leishmania (L.) infantum chagasi. In fact, splenocytesFigure 3 Splenocytes from CD43-deficient mice produce low levels of
5 × 107 amastigotes of Leishmania (L.) infantum chagasi, and 30 days after i
production. After 3 days of in vitro culture with freeze and thawed lysates o
Methods sections, splenocyte supernatants were harvested for determinatio
the levels of cytokines, detected by specific ELISA assays, expressed in ng/m
All experiments were repeated at least 3 times.from CD43−/− mice spontaneously secreted TGF-β as seen
in the unstimulated controls (Figure 3B) and did not de-
crease the production of IL-10 upon stimulation with para-
site antigens as compared to wild-type cells (Figure 2C).
We did not detect significant levels of TNF-α in the cul-
ture supernatants (Data not shown).
The majority of intrahepatic CD4+ and CD8+ T cells with
pro-inflammatory phenotypes express CD43 in visceral
leishmaniasis
We next examined whether the increased parasite load
associated with absence of CD43 influenced the tissue
distribution of intrahepatic T cells. It has been demon-
strated that T cell- and lymphokine-dependent mecha-
nisms are involved in the formation of antileishmanial
tissue granulomas and the acquisition of resistance to
Leishmania infection [22]. Hence we performed experi-
ments to characterize the phenotypic distribution of
intrahepatic T cells based on expression of the CD43
marker. In these experiments, wild-type mice were in-
fected with amastigote forms of Leishmania (L.) infantum
chagasi and the presence of CD4+ and CD8+ T cells in the
spleen and liver was evaluated by FACS at 30 days post-
infection. In both naïve and infected mice, the CD43+ sub-
set in the CD4+ T cell compartment was significantly
smaller than the CD43− population whereas in the CD8+
T cell compartment, the majority of cells expressed CD43
(Figure 4). A striking difference became apparent when
we examined the expression of CD43 in the intrahepa-
tic CD4+ T cell population during infection, as our data
indicated that the majority of the CD4+ T cells, like the
CD8+ T cells, were CD43+ (Figure 4).
Since the CD43 signaling pathway is involved in the T-
bet-dependent expression of IFN-γ by type-1 T cells, we
investigated the cytokine profiles of the T cell subsets
based on the expression of the CD43 marker. Immu-
nosuppression of antigen-specific immune responses due
to impairment of DC activation, and CD4+ and CD8+
T cell exhaustion has been demonstrated in visceralIFN-γ. CD43+/+ and CD43−/− mice were infected intravenously with
nfection splenocytes were isolated and assayed for cytokine
f Leishmania (L.) infantum chagasi promastigotes, as described in the
n of (A) IFN-γ, (B) TGF-β and (C) IL-10 by ELISA. The y-axis represents
l. Asterisks represent statistical significance between groups (p < 0.05).
Figure 4 Expression of CD43+ T cells defines major intrahepatic CD4+ and CD8+ T cell subsets during visceral leishmaniasis. Following
infection of CD43+/+ and CD43−/− mice with 5 × 107amastigotes of Leishmania (L.) infantum chagasi, spleens and livers were collected at 30 DPI
for FACS analysis. Splenocytes and mononuclear cells purified from livers were analyzed by FACS after staining with anti-CD43-FITC, anti-CD8-APC
and anti-CD4-PE. Plots represent CD43+CD8+ and CD43+CD4+ lymphocyte pools derived from five mice. The values in the corners represent mean
percentages of CD43+ cells in the total CD4+ or CD8+ T cell populations. Non-infected mice were used as controls. These data are representative of
three independent experiments, using five mice per group.
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splenic T cells obtained from wild-type infected mice at 30
DPI secreted neither IFN-γ nor TNF-α upon polyclonal
stimulation with an anti-CD3 stimulus (Additional file 1:
Figure S1). Therefore, in order to assess the polarization
profiles of the intrahepatic T cell subsets during infection
we measured changes in the levels of cytokine transcripts.
Total RNA was isolated from CD4+ and CD8+ T cells
sorted by FACS based on the expression of the CD43
marker and purified from the livers of wild-type mice at
30 days post-infection. Real-time RT-PCR analysis re-
vealed a significantly higher level of induction of the pro-
inflammatory cytokines IFN-γ and TNF-α in the CD43+
subset than in the CD43− population (Figure 5). At the
same time we detected a greater reduction of IL-17 and
the regulatory TGF-β and IL-10 cytokines in the CD43+ T
cell subsets, suggesting a role of CD43+ T cells in inflam-
matory responses during infection (Figure 5).
Discussion
The purpose of this study was to elucidate the role of
CD43 in disease progression and immune responses in
mice infected with Leishmania (L.) infantum chagasi.
CD43 (leukosialin, sialophorin) is a large sialoglycopro-
tein that is abundantly expressed by cells of hemopoietic
origin, including both CD4+ and CD8+ T cells [17]. Our
experimental data clearly support a role for CD43 in the
development of resistance to infection with Leishmania
(L.) infantum chagasi, as our findings indicated thatCD43−/− mice were defective in their DTH response to
leishmanial antigens and had a higher hepatic parasite
load.
It has been show in other systems that CD43 is able
to affect the polarization of the Th immune response
[15,16,18,21]. In the M. tuberculosis infection model,
CD43 plays a role in the uptake of M. tuberculosis by
macrophages and in type-1 immune responses [27,28].
Some mechanisms by which CD43 controls the intracel-
lular growth of M. tuberculosis have been described.
These include the induction of apoptosis and the pro-
duction of reactive oxygen intermediates (ROI) and RNI,
which are enhanced by cytokines such as IFN-γ and
TNF-α [29].
Although other studies have demonstrated a role of
the CD43 signaling pathway in the innate defense of
macrophages by increasing the oxidative burden during
tuberculosis infection, we have ruled out this possibility
in the case of Leishmania infection since macrophages
derived from the bone marrow of CD43+ and CD43−
mice were equally effective in eliminating Leishmania
promastigotes (Additional file 2: Figure S2). However,
our results show that protective immune responses elic-
ited via CD43 are required for the increased expression
of IFN-γ, which is associated with protective immune re-
sponses in this model and other murine models of infec-
tion with Leishmania parasites [30].
We further showed that the low levels of IFN-γ in
CD43-deficient mice infected with Leishmania (L.)
Figure 5 Intrahepatic CD43+CD4+ and CD43+CD4+ T cells exibit a pro-inflammatory phenotype in visceral leishmaniasis. Livers were
removed from CD43+/+ wild-type mice infected with 5 × 107 amastigotes of Leishmania (L.) infantum chagasi at 30 DPI and CD43+CD4+ and CD43
+CD8+ T cell subsets were purified by flow cytometry. To measure cytokine transcripts, total mRNA from highly purified (>98%) T cell subsets (as
indicated) were processed for RT-PCR. The results represent (A,F) IFN-γ transcripts, (B,G) TNF-α transcripts, (C,H) IL-17 transcripts, (D,I) IL-10 transcripts,
and (E,J) TGF-β transcripts, standardized with the housekeeping gene GAPDH, calculated as 2-ΔCt and presented as mean values ± SE. All experiments
were performed in triplicate and the data shown are representatives of three independent experiments using five mice per group. Indicated differences
between groups are significant *(p<0.05), **(p<0.01), ***(p<0.001).
Nico et al. Parasites & Vectors  (2015) 8:111 Page 7 of 9infantum chagasi were accompanied by increased pro-
duction of the anti-inflammatory cytokine TGF-β upon
antigenic stimulation, so resulting in a decreased ratio of
IFN-γ/TGF-β compared with wild-type infected mice.
This alteration could lead to macrophage dysfunction
in vivo as it has been shown that increased levels ofTGF-β promote parasite replication inside macrophages
[11]. Beside of its effect on macrophage activation, IFN-
γ stimulates B lymphocytes to produce IgG2a, which
plays a critical role in resistance to leishmaniasis by acti-
vating macrophage defenses through increasing parasite
uptake and anti-parasite activity [23].
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results in reduced levels of IgG2a implying that the type-
1 response to infection is compromised. Our findings
pointed to a critical role of the CD43 on the acquisition of
host protective responses, as we observed striking differ-
ences in the liver parasite burdens under infection with
Leishmania (L.) infantum chagasi indicating a less efficient
control of the parasite replication in CD43-deficient mice
during infection. It has been shown that besides its role as
a regulator of immunity, the CD43 signaling pathway par-
ticipates in the migration and tissue distribution of circu-
lating leukocytes to secondary lymphoid organs and
peripheral tissues [16,19,20].
We have also observed an altered distribution of CD43+
T cells in the periphery, as experimental infection of
wild-type mice with Leishmania (L.) infantum chagasi
yielded an increased proportion of intrahepatic CD43+ T
cells, in both CD4+ and CD8+ subsets, with an effector
profile based on the expression of the major pro-
inflammatory cytokines associated with hepatic control
of parasite load during the acute phase of infection [22].
Our results indicated that the weakened control of the
intrahepatic parasite load was correlated with loss of the
majority of CD43+ CD4+ and CD8+ T cells exhibiting
pro-inflammatory cytokine profiles. In fact, in visceral
leishmaniasis, the acquisition of intrahepatic resistance
to the parasite is a consequence of the tissue expression
of a protective T cell response that promotes the attrac-
tion of competent cells to potentiate the anti-microbial
activity of infected Kupffer cells by inducing the produc-
tion of reactive oxygen and nitrogen intermediates as
well as the pro-inflammatory cytokines IFN-γ and TNF-
α, which play a critical role in liver granuloma formation
and control of parasite colonization [22].Conclusions
Together our data define, for the first time, a role for
CD43 in the hepatic protective immune response against
parasite reservoirs in visceral leishmaniasis. We observed
that CD43−/− mice were more susceptible to the disease,
which implies that sialoprotein participates in disease
resolution and elimination of the parasite. More specific-
ally we demonstrated that loss of CD43 signaling path-
way resulted in a modulation of the cytokine balance,
with a significant decrease in the IFN-γ type 1 response,
which is essential for elimination of the parasite. A suc-
cessful immune response is also correlated with the di-
minished production of the anti-inflammatory cytokine,
TGF-β, which promotes susceptibility to the disease. Un-
derstanding how host protective immune responses can
affect the intracellular growth of Leishmania parasites
could lead to the development of novel therapeutic or
preventative measures against this devastating pathogen.Additional files
Additional file 1: Figure S1. Flow cytometric analysis of intracellular
IFN-γ in T cells from visceral leishmaniasis. Spleens from CD43+/+ wild-type
mice were collected on day 30 after infection with 5 x 107amastigotes of L.
(L) infantum chagasi to assay intracellular expression for IFN-γ. Splenocytes
were stimulated with plate-bound anti-CD3 (5 μg/mL), in the presence of
GolgiPlug (brefeldin A) for 6 h at 37oC in 5% CO2. Samples were stained with
CD3-FITC, CD4-Cy-Chrome (A) and CD8-APC (B) and then intracellularly with
IFN-γ PE as described in Methods. Results are representative of duplicate
cultures from three different experiments.
Additional file 2: Figure S2. Bone marrow-derived macrophages from
CD43-/- and wild-type cells have similar levels of infectivity with Leishmania
(L.) chagasi promastigotes. Bone marrow-derived macrophages generated
from CD43+/+ and CD43-/- mice were infected with amastigotes at a 10:1
ratio of parasites: host cells. At 1 hour after infection, cells were washed to
determine the % infection, and the cultures were incubated for a further 72
hours to measure intracellular growth of the amastigote forms. The number
of intracellular parasites per 100 cell nuclei was determined after citospinning
the cells onto glass slides, followed by fixation and Giemsa staining. Data
represent the mean ± SEM of triplicate assays and are representative of two
independent experiments.
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